HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Clarins sales

This article was originally published in The Rose Sheet

Executive Summary

Third quarter net sales increase 5.1% to $184.7 mil. (€=$.91) on like-for-like currency basis despite weaker sales in September, which were "severely affected" by the Sept. 11 terrorist attacks, according to 1Clarins' sales release. As "global luxury cosmetics market offers very limited visibility," Clarins said it can no longer affirm that it will meet its sales objectives for the year. For the nine months, Clarins brand sales were up 4.6% to $357.5 mil. on like-for-like currency basis, and Azzaro sales increased 6.6% to $59.9 mil. Perfume distribution sales grew 8.8% to $55.8 mil. Sales gains reflect momentum recovery following logistics problems in the first quarter, firm says...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009764

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel